Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00750152 · ClinicalTrials.gov registry record · Phase 3
Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris
A Phase 3 study, sponsored by Merz North America.
- Completed
- Registry status
- Phase 3
- Development phase
- 334
- Enrollment target
NCT00750152: Completed Phase 3 study, sponsored by Merz North America.
NCT00750152 is a Phase 3 study that has completed, run by Merz North America. The registered enrollment target is 334 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00750152, a Phase 3 study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 334 participants
- Enrollment target
Study Summary
A research study to compare the safety and effectiveness of an investigational medication called NAFT-500 to placebo (no active treatment), when used in subjects with tinea cruris, also known as jock itch.
Primary Outcome
Complete cure is defined as negative mycology results from the central laboratory (dermatophyte culture and KOH) and absence of Erythema, Scaling, and Pruritus (grade 0 for each) evaluated using the 5-point severity grading scale: 0 = absent, 1 = mild, 2 = moderate, 3 = marked, and 4 = not done.
Interventions
- DRUG Placebo
- DRUG NAFT-500
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-02 |
| Phase | Phase 3 |
What the finished NCT00750152 record still lists
NCT00750152 is an interventional study that assigns participants to a tested intervention. The registered 334 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00750152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00750152 about?
NCT00750152 is a clinical study titled "Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris". A research study to compare the safety and effectiveness of an investigational medication called NAFT-500 to placebo (no active treatment), when used in subjects with tinea cruris, also known as jock itch.
What is the current status of trial NCT00750152?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 334 participants. The study started on 2008-09. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00750152?
The interventions under investigation include: Placebo (DRUG), NAFT-500 (DRUG).
Who is sponsoring clinical trial NCT00750152?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00750152's enrollment target sits among peer trials
334 1061st of 2000 higher than 940 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
- NCT05722197 · 334 participants · NA
Assessment of Emotion Regulation Strategies Used When Suicidal
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia